nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—penis—type 2 diabetes mellitus	0.0992	0.357	CbGeAlD
Icatibant—BDKRB2—islet of Langerhans—type 2 diabetes mellitus	0.0221	0.0794	CbGeAlD
Icatibant—BDKRB2—nephron tubule—type 2 diabetes mellitus	0.0178	0.0639	CbGeAlD
Icatibant—BDKRB2—kidney—type 2 diabetes mellitus	0.0156	0.0562	CbGeAlD
Icatibant—BDKRB2—pancreas—type 2 diabetes mellitus	0.0155	0.0558	CbGeAlD
Icatibant—BDKRB2—cortex of kidney—type 2 diabetes mellitus	0.0152	0.0547	CbGeAlD
Icatibant—BDKRB2—adipose tissue—type 2 diabetes mellitus	0.0141	0.0506	CbGeAlD
Icatibant—ANPEP—islet of Langerhans—type 2 diabetes mellitus	0.0138	0.0495	CbGeAlD
Icatibant—ANPEP—nephron tubule—type 2 diabetes mellitus	0.0111	0.0398	CbGeAlD
Icatibant—ANPEP—cardiovascular system—type 2 diabetes mellitus	0.00995	0.0358	CbGeAlD
Icatibant—ANPEP—kidney—type 2 diabetes mellitus	0.00974	0.035	CbGeAlD
Icatibant—ANPEP—pancreas—type 2 diabetes mellitus	0.00967	0.0348	CbGeAlD
Icatibant—ANPEP—cortex of kidney—type 2 diabetes mellitus	0.00948	0.0341	CbGeAlD
Icatibant—ANPEP—adipose tissue—type 2 diabetes mellitus	0.00878	0.0316	CbGeAlD
Icatibant—ANPEP—liver—type 2 diabetes mellitus	0.00616	0.0221	CbGeAlD
Icatibant—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00468	0.017	CcSEcCtD
Icatibant—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00379	0.0137	CcSEcCtD
Icatibant—Rash—Miglitol—type 2 diabetes mellitus	0.00364	0.0132	CcSEcCtD
Icatibant—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00364	0.0132	CcSEcCtD
Icatibant—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00358	0.013	CcSEcCtD
Icatibant—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00351	0.0127	CcSEcCtD
Icatibant—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00345	0.0125	CcSEcCtD
Icatibant—Nausea—Miglitol—type 2 diabetes mellitus	0.00343	0.0124	CcSEcCtD
Icatibant—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00334	0.0121	CcSEcCtD
Icatibant—Rash—Tolbutamide—type 2 diabetes mellitus	0.00327	0.0119	CcSEcCtD
Icatibant—Headache—Tolbutamide—type 2 diabetes mellitus	0.00325	0.0118	CcSEcCtD
Icatibant—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00323	0.0117	CcSEcCtD
Icatibant—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00312	0.0113	CcSEcCtD
Icatibant—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00312	0.0113	CcSEcCtD
Icatibant—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00309	0.0112	CcSEcCtD
Icatibant—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.003	0.0109	CcSEcCtD
Icatibant—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00298	0.0108	CcSEcCtD
Icatibant—Rash—Tolazamide—type 2 diabetes mellitus	0.00298	0.0108	CcSEcCtD
Icatibant—Headache—Tolazamide—type 2 diabetes mellitus	0.00296	0.0107	CcSEcCtD
Icatibant—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00296	0.0107	CcSEcCtD
Icatibant—Rash—Linagliptin—type 2 diabetes mellitus	0.00295	0.0107	CcSEcCtD
Icatibant—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00295	0.0107	CcSEcCtD
Icatibant—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00295	0.0107	CcSEcCtD
Icatibant—Headache—Linagliptin—type 2 diabetes mellitus	0.00293	0.0106	CcSEcCtD
Icatibant—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00293	0.0106	CcSEcCtD
Icatibant—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00292	0.0106	CcSEcCtD
Icatibant—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00289	0.0105	CcSEcCtD
Icatibant—Rash—Acarbose—type 2 diabetes mellitus	0.00286	0.0104	CcSEcCtD
Icatibant—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00286	0.0104	CcSEcCtD
Icatibant—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00286	0.0104	CcSEcCtD
Icatibant—Nausea—Tolazamide—type 2 diabetes mellitus	0.00281	0.0102	CcSEcCtD
Icatibant—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00281	0.0102	CcSEcCtD
Icatibant—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00279	0.0101	CcSEcCtD
Icatibant—Rash—Nateglinide—type 2 diabetes mellitus	0.00276	0.01	CcSEcCtD
Icatibant—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00276	0.01	CcSEcCtD
Icatibant—Nausea—Acarbose—type 2 diabetes mellitus	0.0027	0.00978	CcSEcCtD
Icatibant—Nausea—Nateglinide—type 2 diabetes mellitus	0.0026	0.00943	CcSEcCtD
Icatibant—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00259	0.00939	CcSEcCtD
Icatibant—Rash—Repaglinide—type 2 diabetes mellitus	0.00239	0.00867	CcSEcCtD
Icatibant—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00239	0.00866	CcSEcCtD
Icatibant—Headache—Repaglinide—type 2 diabetes mellitus	0.00237	0.00861	CcSEcCtD
Icatibant—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00237	0.00859	CcSEcCtD
Icatibant—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00237	0.00858	CcSEcCtD
Icatibant—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00231	0.00838	CcSEcCtD
Icatibant—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00226	0.00819	CcSEcCtD
Icatibant—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00226	0.00819	CcSEcCtD
Icatibant—Nausea—Repaglinide—type 2 diabetes mellitus	0.00225	0.00817	CcSEcCtD
Icatibant—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00224	0.00814	CcSEcCtD
Icatibant—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00221	0.00803	CcSEcCtD
Icatibant—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00216	0.00782	CcSEcCtD
Icatibant—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00215	0.0078	CcSEcCtD
Icatibant—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00213	0.00772	CcSEcCtD
Icatibant—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00212	0.00771	CcSEcCtD
Icatibant—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00209	0.00757	CcSEcCtD
Icatibant—Dizziness—Glipizide—type 2 diabetes mellitus	0.00207	0.00752	CcSEcCtD
Icatibant—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00199	0.00722	CcSEcCtD
Icatibant—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00199	0.00721	CcSEcCtD
Icatibant—Rash—Glipizide—type 2 diabetes mellitus	0.00198	0.00717	CcSEcCtD
Icatibant—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00197	0.00717	CcSEcCtD
Icatibant—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00197	0.00714	CcSEcCtD
Icatibant—Headache—Glipizide—type 2 diabetes mellitus	0.00196	0.00713	CcSEcCtD
Icatibant—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00195	0.00708	CcSEcCtD
Icatibant—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00193	0.00702	CcSEcCtD
Icatibant—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00193	0.007	CcSEcCtD
Icatibant—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00193	0.007	CcSEcCtD
Icatibant—Headache—Pioglitazone—type 2 diabetes mellitus	0.00188	0.00683	CcSEcCtD
Icatibant—Nausea—Glipizide—type 2 diabetes mellitus	0.00186	0.00676	CcSEcCtD
Icatibant—Rash—Glimepiride—type 2 diabetes mellitus	0.00184	0.00669	CcSEcCtD
Icatibant—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00184	0.00669	CcSEcCtD
Icatibant—Rash—Sitagliptin—type 2 diabetes mellitus	0.00184	0.00667	CcSEcCtD
Icatibant—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00184	0.00667	CcSEcCtD
Icatibant—Headache—Glimepiride—type 2 diabetes mellitus	0.00183	0.00665	CcSEcCtD
Icatibant—Headache—Sitagliptin—type 2 diabetes mellitus	0.00183	0.00663	CcSEcCtD
Icatibant—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00178	0.00645	CcSEcCtD
Icatibant—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00178	0.00645	CcSEcCtD
Icatibant—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00175	0.00633	CcSEcCtD
Icatibant—Nausea—Glimepiride—type 2 diabetes mellitus	0.00174	0.00631	CcSEcCtD
Icatibant—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00173	0.00629	CcSEcCtD
Icatibant—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00171	0.00621	CcSEcCtD
Icatibant—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00171	0.00621	CcSEcCtD
Icatibant—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00168	0.00609	CcSEcCtD
Icatibant—Rash—Bromocriptine—type 2 diabetes mellitus	0.00166	0.00604	CcSEcCtD
Icatibant—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00166	0.00603	CcSEcCtD
Icatibant—Headache—Bromocriptine—type 2 diabetes mellitus	0.00165	0.006	CcSEcCtD
Icatibant—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00161	0.00584	CcSEcCtD
Icatibant—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0016	0.00579	CcSEcCtD
Icatibant—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00158	0.00573	CcSEcCtD
Icatibant—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00157	0.00569	CcSEcCtD
Icatibant—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00155	0.00564	CcSEcCtD
Icatibant—Rash—Glyburide—type 2 diabetes mellitus	0.00152	0.00552	CcSEcCtD
Icatibant—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00152	0.00551	CcSEcCtD
Icatibant—Headache—Glyburide—type 2 diabetes mellitus	0.00151	0.00548	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00151	0.00338	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	0.00151	0.00338	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—type 2 diabetes mellitus	0.0015	0.00337	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	0.0015	0.00336	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—GPX1—type 2 diabetes mellitus	0.00149	0.00333	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.00148	0.00331	CbGpPWpGaD
Icatibant—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00147	0.00532	CcSEcCtD
Icatibant—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00145	0.00526	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.00145	0.00324	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PTGS2—type 2 diabetes mellitus	0.00144	0.00323	CbGpPWpGaD
Icatibant—Nausea—Glyburide—type 2 diabetes mellitus	0.00143	0.0052	CcSEcCtD
Icatibant—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00143	0.0052	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.00141	0.00317	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—ADRA2A—type 2 diabetes mellitus	0.00141	0.00316	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—FAS—type 2 diabetes mellitus	0.00139	0.00312	CbGpPWpGaD
Icatibant—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00138	0.00501	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	0.00138	0.00309	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.00137	0.00308	CbGpPWpGaD
Icatibant—Rash—Gliclazide—type 2 diabetes mellitus	0.00137	0.00496	CcSEcCtD
Icatibant—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00136	0.00495	CcSEcCtD
Icatibant—Headache—Gliclazide—type 2 diabetes mellitus	0.00136	0.00492	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	0.00136	0.00304	CbGpPWpGaD
Icatibant—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00135	0.00491	CcSEcCtD
Icatibant—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00135	0.00491	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.00134	0.00299	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	0.00133	0.00297	CbGpPWpGaD
Icatibant—Dizziness—Valsartan—type 2 diabetes mellitus	0.00132	0.00478	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—BCL2L1—type 2 diabetes mellitus	0.00131	0.00294	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	0.00131	0.00293	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.00131	0.00293	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.0013	0.00292	CbGpPWpGaD
Icatibant—Dizziness—Orlistat—type 2 diabetes mellitus	0.0013	0.00472	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—AVP—type 2 diabetes mellitus	0.00129	0.0029	CbGpPWpGaD
Icatibant—Nausea—Gliclazide—type 2 diabetes mellitus	0.00129	0.00467	CcSEcCtD
Icatibant—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00127	0.00462	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.00127	0.00284	CbGpPWpGaD
Icatibant—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00126	0.00457	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00126	0.00282	CbGpPWpGaD
Icatibant—Rash—Valsartan—type 2 diabetes mellitus	0.00126	0.00455	CcSEcCtD
Icatibant—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00125	0.00455	CcSEcCtD
Icatibant—Headache—Valsartan—type 2 diabetes mellitus	0.00125	0.00452	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	0.00125	0.00279	CbGpPWpGaD
Icatibant—Rash—Orlistat—type 2 diabetes mellitus	0.00124	0.0045	CcSEcCtD
Icatibant—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00124	0.0045	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.00124	0.00277	CbGpPWpGaD
Icatibant—Headache—Orlistat—type 2 diabetes mellitus	0.00123	0.00447	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—EDN1—type 2 diabetes mellitus	0.00123	0.00276	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	0.00122	0.00274	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—DPP4—type 2 diabetes mellitus	0.00122	0.00274	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.00121	0.00272	CbGpPWpGaD
Icatibant—Dizziness—Metformin—type 2 diabetes mellitus	0.0012	0.00435	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	0.00119	0.00266	CbGpPWpGaD
Icatibant—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00119	0.0043	CcSEcCtD
Icatibant—Nausea—Valsartan—type 2 diabetes mellitus	0.00118	0.00429	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—GIP—type 2 diabetes mellitus	0.00118	0.00264	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00118	0.00264	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	0.00117	0.00262	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	0.00117	0.00262	CbGpPWpGaD
Icatibant—Nausea—Orlistat—type 2 diabetes mellitus	0.00117	0.00424	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00115	0.00258	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00114	0.00256	CbGpPWpGaD
Icatibant—Rash—Metformin—type 2 diabetes mellitus	0.00114	0.00415	CcSEcCtD
Icatibant—Dermatitis—Metformin—type 2 diabetes mellitus	0.00114	0.00414	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	0.00114	0.00255	CbGpPWpGaD
Icatibant—Headache—Metformin—type 2 diabetes mellitus	0.00114	0.00412	CcSEcCtD
Icatibant—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00113	0.0041	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00112	0.00252	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00112	0.00251	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00112	0.00251	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.00112	0.0025	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	0.00111	0.0025	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—GNB3—type 2 diabetes mellitus	0.00111	0.00248	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.0011	0.00247	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	0.0011	0.00247	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR5—type 2 diabetes mellitus	0.0011	0.00246	CbGpPWpGaD
Icatibant—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00109	0.00396	CcSEcCtD
Icatibant—Rash—Irbesartan—type 2 diabetes mellitus	0.00108	0.00391	CcSEcCtD
Icatibant—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00108	0.00391	CcSEcCtD
Icatibant—Nausea—Metformin—type 2 diabetes mellitus	0.00108	0.00391	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—C3—type 2 diabetes mellitus	0.00107	0.00241	CbGpPWpGaD
Icatibant—Headache—Irbesartan—type 2 diabetes mellitus	0.00107	0.00389	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.00107	0.00239	CbGpPWpGaD
Icatibant—Dizziness—Losartan—type 2 diabetes mellitus	0.00106	0.00386	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	0.00103	0.00232	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—AGT—type 2 diabetes mellitus	0.00102	0.00229	CbGpPWpGaD
Icatibant—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00102	0.00369	CcSEcCtD
Icatibant—Nausea—Irbesartan—type 2 diabetes mellitus	0.00102	0.00369	CcSEcCtD
Icatibant—Rash—Losartan—type 2 diabetes mellitus	0.00102	0.00368	CcSEcCtD
Icatibant—Dermatitis—Losartan—type 2 diabetes mellitus	0.00101	0.00368	CcSEcCtD
Icatibant—Headache—Losartan—type 2 diabetes mellitus	0.00101	0.00366	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—SERPINE1—type 2 diabetes mellitus	0.001	0.00225	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000993	0.00222	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—ADCY5—type 2 diabetes mellitus	0.000986	0.00221	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.000983	0.0022	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.000983	0.0022	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.00097	0.00217	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.000964	0.00216	CbGpPWpGaD
Icatibant—Nausea—Losartan—type 2 diabetes mellitus	0.000956	0.00347	CcSEcCtD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR5—type 2 diabetes mellitus	0.000928	0.00208	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	0.000925	0.00207	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000923	0.00207	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—BCL2—type 2 diabetes mellitus	0.000921	0.00206	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000918	0.00206	CbGpPWpGaD
Icatibant—Dizziness—Ramipril—type 2 diabetes mellitus	0.000913	0.00331	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3R1—type 2 diabetes mellitus	0.00091	0.00204	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—C3—type 2 diabetes mellitus	0.000907	0.00203	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000899	0.00201	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000896	0.00201	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000893	0.002	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000893	0.002	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000872	0.00195	CbGpPWpGaD
Icatibant—Rash—Ramipril—type 2 diabetes mellitus	0.00087	0.00316	CcSEcCtD
Icatibant—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00087	0.00315	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.000867	0.00194	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000865	0.00194	CbGpPWpGaD
Icatibant—Headache—Ramipril—type 2 diabetes mellitus	0.000865	0.00314	CcSEcCtD
Icatibant—BDKRB2—G alpha (i) signalling events—AGT—type 2 diabetes mellitus	0.000861	0.00193	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.000861	0.00193	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000853	0.00191	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000849	0.0019	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—type 2 diabetes mellitus	0.000841	0.00188	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.00084	0.00188	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000839	0.00188	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000825	0.00185	CbGpPWpGaD
Icatibant—Nausea—Ramipril—type 2 diabetes mellitus	0.00082	0.00297	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000816	0.00183	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000816	0.00183	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000786	0.00176	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000777	0.00174	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.000759	0.0017	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000738	0.00165	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000736	0.00165	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000733	0.00164	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000721	0.00162	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.000714	0.0016	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000711	0.00159	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000685	0.00153	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.000679	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.00067	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000668	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000664	0.00149	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000661	0.00148	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000653	0.00146	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.00065	0.00146	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000645	0.00145	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000633	0.00142	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000633	0.00142	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000628	0.00141	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000623	0.0014	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—EGFR—type 2 diabetes mellitus	0.00062	0.00139	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000608	0.00136	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000597	0.00134	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.00059	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—EGFR—type 2 diabetes mellitus	0.00059	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000575	0.00129	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000573	0.00128	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000566	0.00127	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000564	0.00126	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000562	0.00126	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000561	0.00126	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000549	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000548	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000545	0.00122	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000527	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000527	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000522	0.00117	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000522	0.00117	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000515	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000509	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000506	0.00113	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000506	0.00113	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000497	0.00111	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000495	0.00111	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000493	0.0011	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000482	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000482	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.00048	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000474	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000474	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000464	0.00104	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.00046	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000447	0.001	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000441	0.000988	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.00044	0.000986	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000439	0.000984	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000438	0.000981	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000436	0.000977	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000432	0.000968	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000431	0.000965	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.00043	0.000962	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000422	0.000945	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.00041	0.000919	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000406	0.00091	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000401	0.000899	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000399	0.000893	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000395	0.000884	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.000393	0.000881	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000392	0.000879	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000381	0.000854	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000378	0.000848	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000373	0.000836	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000355	0.000796	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000352	0.000788	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000349	0.000781	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000349	0.000781	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000344	0.00077	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00034	0.000761	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00034	0.000761	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000339	0.00076	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000339	0.00076	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000338	0.000758	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000337	0.000756	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—INS—type 2 diabetes mellitus	0.000336	0.000752	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000334	0.000749	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—type 2 diabetes mellitus	0.00033	0.00074	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—IGF1—type 2 diabetes mellitus	0.000325	0.000728	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000322	0.000722	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000317	0.000711	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.00031	0.000695	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000306	0.000686	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000303	0.000679	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000301	0.000674	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000299	0.00067	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000295	0.00066	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000294	0.000658	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000294	0.000658	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000292	0.000655	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000288	0.000646	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000282	0.000631	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.00028	0.000627	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000272	0.00061	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000272	0.000609	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000272	0.000609	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000268	0.0006	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000264	0.000592	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000263	0.00059	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000263	0.000589	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000259	0.000579	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000258	0.000577	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000258	0.000577	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000254	0.00057	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000247	0.000554	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.00024	0.000537	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000238	0.000534	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000236	0.000528	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000236	0.000528	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000232	0.000519	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000231	0.000518	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.00022	0.000494	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000217	0.000485	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000216	0.000485	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000205	0.000459	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000203	0.000455	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	0.0002	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.0002	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000199	0.000447	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000198	0.000445	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000196	0.00044	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000194	0.000434	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000193	0.000432	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.00019	0.000427	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000185	0.000414	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000181	0.000405	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000173	0.000389	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.00017	0.000382	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C3—type 2 diabetes mellitus	0.000166	0.000373	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000159	0.000356	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000158	0.000355	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000158	0.000354	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000155	0.000348	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000155	0.000347	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000155	0.000347	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000153	0.000343	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000146	0.000327	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000138	0.00031	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—INS—type 2 diabetes mellitus	0.000132	0.000297	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.00013	0.000292	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000128	0.000287	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000128	0.000287	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000127	0.000285	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000122	0.000272	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000116	0.00026	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000116	0.00026	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000109	0.000245	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.94e-05	0.000223	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.85e-05	0.000221	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.79e-05	0.000219	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.31e-05	0.000209	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.21e-05	0.000206	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.03e-05	0.000202	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.58e-05	0.000192	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.36e-05	0.000187	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.67e-05	0.000172	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.52e-05	0.000169	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.78e-05	0.00013	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.33e-05	0.00012	CbGpPWpGaD
